Allelotypes as potential prognostic markers in ovarian carcinoma treated with cisplatin-based chemotherapy.

International journal of molecular medicine

Volumn 11, Issue 5, 2003, Pages 621-625

  Nakayama, Satoru ^a   Nakayama, Kentaro ^a   Takebayashi, Yuji ^a   Hata, Kohkichi ^a   Fujiwaki, Ritsuto ^a   Fukumoto, Manabu ^a   Miyazaki, Kohji ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; MICROSATELLITE DNA; TUMOR MARKER;

ALLELE; ARTICLE; CARCINOMA; FEMALE; GENETICS; HETEROZYGOSITY LOSS; HUMAN; OVARY TUMOR; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

ALLELES; ANTINEOPLASTIC AGENTS; CARCINOMA; CISPLATIN; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; OVARIAN NEOPLASMS; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0642286397     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.11.5.621     Document Type: Article

References (0)